Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Aiden Liu"'
Autor:
Serena Wong, Bridget Dolan, Fawaz Al‐Mutfi, Brittany Russo, Chaitanya Medicherla, Kevin Clare, Aiden Liu
Publikováno v:
Stroke: Vascular and Interventional Neurology, Vol 3, Iss S2 (2023)
Introduction Cardiomyopathy (CM) is a diverse pathology defined by both structural and functional changes in the heart. Many studies have aimed to determine if heart failure (HF) is an independent risk factor in the development of AIS, but there is a
Externí odkaz:
https://doaj.org/article/5a60e167571b4a4982b3b0d5b2e29c25
Autor:
Sean Wharton, Christiane L. Haase, Elham Kamran, Aiden Liu, Johanna Mancini, Drew Neish, Arash Pakseresht, G Sarah Power, Rebecca A. G. Christensen
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 4, Pp 439-444 (2020)
Summary Objective Liraglutide 3.0 mg is associated with clinically significant weight loss in clinical trials, but real‐world data are lacking. In this analysis, weight loss and persistence outcomes with liraglutide 3.0 mg were assessed across obes
Externí odkaz:
https://doaj.org/article/40a7c9a759e64874b3401670449e4ac1
Autor:
Sean Wharton, Christiane L Haase, Elham Kamran, Aiden Liu, Johanna Mancini, Drew Neish, Arash Pakseresht, G Sarah Power, Rebecca AG Christensen
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 4, Pp 382-389 (2020)
Summary Objective Weight management medications can significantly increase patients' chances of achieving a clinically meaningful weight loss if patients persist with treatment. This retrospective observational study of de‐identified medical record
Externí odkaz:
https://doaj.org/article/b1e41395ee644095b92b842ca20e8a0b
Publikováno v:
Tuesday, April 25.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dfb413ffcbdfdb5d6bdc4c0f9a2d346c
https://doi.org/10.1212/wnl.0000000000204003
https://doi.org/10.1212/wnl.0000000000204003
Autor:
Alice Y.Y. Cheng, Ronald Goldenberg, Iris Krawchenko, Richard Tytus, Jina Hahn, Aiden Liu, Shane Golden, Brad Millson, Stewart Harris
Publikováno v:
Canadian Journal of Diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::269802591728b29e55e5c3f1904b0623
https://doi.org/10.1016/j.jcjd.2023.03.001
https://doi.org/10.1016/j.jcjd.2023.03.001
Autor:
Alice Y.Y. Cheng, Stewart Harris, Iris Krawchenko, Richard Tytus, Jina Hahn, Aiden Liu, Brad Millson, Shane Golden, Ronald Goldenberg
Publikováno v:
Canadian Journal of Diabetes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::994fef2ed53554382dd3cdcf72451de0
https://doi.org/10.1016/j.jcjd.2023.01.003
https://doi.org/10.1016/j.jcjd.2023.01.003
Autor:
Kamran, Qureshy, Andreas, Ross Kirk, Michael, Lyng Wolden, Amir, Abbas Mohseni Zonoozi, Aiden, Liu
Publikováno v:
Cardiovascular Endocrinology & Metabolism. 11
We assessed physicians' experiences of prescribing once-weekly (OW) semaglutide to patients with type 2 diabetes (T2D) in Canada. Physicians who had prescribed OW semaglutide to ≥2 patients with T2D in the past 12 months and had been doing so for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ba8880a3866a170fb7956eedfe6edb
https://doi.org/10.1097/xce.0000000000000260
https://doi.org/10.1097/xce.0000000000000260
Autor:
G Sarah Power, Aiden Liu, Elham Kamran, Arash Pakseresht, Sean Wharton, Drew Neish, Rebecca A. G. Christensen, Christiane L Haase, Johanna Mancini
Publikováno v:
Obesity Science & Practice, Vol 6, Iss 4, Pp 439-444 (2020)
Obesity Science & Practice
Obesity Science & Practice
Summary Objective Liraglutide 3.0 mg is associated with clinically significant weight loss in clinical trials, but real‐world data are lacking. In this analysis, weight loss and persistence outcomes with liraglutide 3.0 mg were assessed across obes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04edfd3aa95e3512539f98a383874289
https://doi.org/10.1002/osp4.420
https://doi.org/10.1002/osp4.420
Autor:
Sara Stafford, Peter G. Bech, Adam Fridhammar, Nino Miresashvili, Andreas Nilsson, Michael Willis, Aiden Liu
Publikováno v:
Applied health economics and health policy. 20(4)
Our objective was to evaluate the long-term cost-effectiveness of once-weekly semaglutide 1 mg versus once-daily canagliflozin 300 mg in patients with type 2 diabetes mellitus (T2DM) uncontrolled with metformin from the healthcare payer and societal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3485a79e01e58cbb945fc18b683daae2
https://pubmed.ncbi.nlm.nih.gov/35441978
https://pubmed.ncbi.nlm.nih.gov/35441978
Autor:
Sara Stafford, Peter G. Bech, Adam Fridhammar, Nino Miresashvili, Andreas Nilsson, Michael Willis, Aiden Liu
Publikováno v:
Applied Health Economics and Health Policy. 20:623-623
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45cb6c7a0481ae6ef0d1ef21a334d579
https://doi.org/10.1007/s40258-022-00734-z
https://doi.org/10.1007/s40258-022-00734-z